Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Types of Viral Infections
  • Track 1-2Diagnosing Viral Infections
  • Track 1-3Symptoms of Viral Infections
  • Track 1-4Viral Infections vs. Bacterial Infection
  • Track 1-5Persistent Viral Infections
  • Track 1-6Causes of Viral Infections
  • Track 1-7Preventive Measures for Viral Infections
  • Track 2-1Mutations
  • Track 2-2Recombination
  • Track 2-3Vaccines
  • Track 2-4Gene Therapy
  • Track 2-5Viral Proteins and Nucleic Acids
  • Track 2-6Genomic Diversity
  • Track 3-1Antiviral drugs
  • Track 3-2Anti-viral therapy
  • Track 3-3Anti-Viral targeting
  • Track 3-4Antibiotics vs. Antivirals
  • Track 3-5Mechanism of action of Anti-Viral agents and drugs
  • Track 3-6Developing an anti-viral drug
  • Track 4-1Principles of Zoonotic Virology
  • Track 4-2Pathogenesis of Zoonotic viruses
  • Track 4-3Diagnosis of Zoonotic Viral infections
  • Track 4-4Zoonotic Viruses
  • Track 4-5Prions
  • Track 5-1Examination of specimen
  • Track 5-2Techniques in Serology
  • Track 5-3Antiviral Susceptibility Testing
  • Track 5-4Diagnosis in Cerebro-Spinal Fluids
  • Track 5-5Limitations of Diagnostic Tests
  • Track 5-6Diagnostic Tests
  • Track 6-1Transmission of plant viruses
  • Track 6-2Types of plant viruses
  • Track 6-3Viroids
  • Track 6-4Plant Viruses of Economic Importance
  • Track 6-5Plant Virus Gene Bank
  • Track 6-6Molecular Plant Pathology
  • Track 6-7Virus Resistant Plants
  • Track 7-1Humoral Response
  • Track 7-2Cell Mediated Response
  • Track 7-3virus-specific antibodies
  • Track 7-4Specificity of viral test methods
  • Track 7-5Viral Immuno-pathology
  • Track 8-1Nanotechnology in Viral infections
  • Track 8-2Regulation of Nano biotechnology
  • Track 8-3Limitations of viro-nanobiotechnology
  • Track 8-4Nano-bioviruses as weapons
  • Track 9-1EEE- Emergence, Evolution & Epidemiology
  • Track 9-2Case-Control Studies
  • Track 9-3Disease Eradication
  • Track 9-4Re-emerging Viruses & Viral Epidemics
  • Track 9-5Outbreak Prevention and Containment
  • Track 9-6Epidemic, Pandemic and Endemic
  • Track 10-1Neuro-viruses & viral infections
  • Track 10-2Viral entry into nervous system
  • Track 10-3Mechanism of spread of infection
  • Track 10-4Neuro-viral infections diagnosis & prognosis
  • Track 10-5Neuro-imaging
  • Track 10-6Research & Therapy
  • Track 11-1Aspects of viral infection and host response
  • Track 11-2Adaptive Defenses
  • Track 11-3Cytotoxic Cells
  • Track 11-4Interferons
  • Track 11-5Antibodies
  • Track 12-1Outbreak Investigations
  • Track 12-2Surveillance of the symptomatic patients
  • Track 12-3Detection and Control
  • Track 12-4Warning System for Emerging and Re-emerging Viruses
  • Track 12-5Plan a long-term prevention and control
  • Track 13-1Ebola Virus Disease
  • Track 13-2Vaccine
  • Track 13-3Causes and Symptoms
  • Track 13-4Diagnosis and Treatment